triazoles has been researched along with eszopiclone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binns, J; Bowlby, MR; Brunner, J; Cannon, CE; Coleman, PJ; Eddins, DM; Fox, SV; Garson, SL; Gotter, AL; Hodgson, R; Kuduk, SD; Mcdonald, TP; Renger, JJ; Savitz, AT; Stevens, J; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Wang, X; Winrow, CJ; Yao, L | 1 |
| Bowlby, MR; Brunner, JI; Coleman, PJ; Fox, SV; Garson, SL; Gotter, AL; Hargreaves, R; Hodgson, R; Kuduk, SD; McDonald, TP; Renger, JJ; Savitz, AT; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Winrow, CJ; Yao, L | 1 |
| Coleman, PJ; Fox, SV; Garson, SL; Gotter, AL; Kuduk, SD; McDonald, T; Munden, RL; Renger, JJ; Stevens, J; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Winrow, CJ; Yao, L | 1 |
| Coleman, PJ; Fox, SV; Gotter, AL; Hargreaves, R; Kuduk, SD; Renger, JJ; Savitz, AT; Stevens, J; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Winrow, CJ | 1 |
| Akiyama, M; Ishida, H; Kitahara, T; Kouda, K; Matsunaga, K; Saisyo, A; Takasago, M; Takasaki, A; Wakabayashi, K | 1 |
5 other study(ies) available for triazoles and eszopiclone
| Article | Year |
|---|---|
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.
Topics: Administration, Oral; Animals; Attention; Azabicyclo Compounds; Choice Behavior; Cognition; Cytoskeletal Proteins; Diazepam; Eszopiclone; gamma-Aminobutyric Acid; Hippocampus; Hypnotics and Sedatives; Macaca mulatta; Male; Memory, Short-Term; Nerve Tissue Proteins; Orexin Receptors; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Recognition, Psychology; Sleep; Task Performance and Analysis; Time Factors; Triazoles; Zolpidem | 2013 |
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.
Topics: Animals; Azabicyclo Compounds; Brain; Electroencephalography; Eszopiclone; GABA-A Receptor Agonists; Male; Orexin Receptor Antagonists; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Sleep Stages; Triazoles; Zolpidem | 2013 |
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators.
Topics: Animals; Azabicyclo Compounds; Azepines; Benzimidazoles; Brain; Cross-Over Studies; Dogs; Electroencephalography; Eszopiclone; GABA Modulators; Hypnotics and Sedatives; Intracellular Signaling Peptides and Proteins; Macaca mulatta; Male; Mice, Inbred C57BL; Neurons; Neuropeptides; Orexin Receptor Antagonists; Orexins; Piperazines; Piperidines; Rats, Sprague-Dawley; Rats, Transgenic; Sleep; Sleep Deprivation; Sleep Stages; Species Specificity; Triazoles; Wakefulness | 2014 |
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys.
Topics: Animals; Arousal; Conditioning, Classical; Cross-Over Studies; Diazepam; Eszopiclone; GABA Agents; Hypnotics and Sedatives; Macaca mulatta; Male; Orexin Receptor Antagonists; Orexins; Piperidines; Polysomnography; Signal Transduction; Sleep; Sleep Stages; Triazoles; Wakefulness | 2016 |
[Standardization of Hypnotic Agents for Prevention of Falls: A Pharmacoeconomic Study].
Topics: Accidental Falls; Aged; Aged, 80 and over; Azepines; Benzodiazepines; Cost-Benefit Analysis; Economics, Pharmaceutical; Eszopiclone; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Sleep Initiation and Maintenance Disorders; Triazoles | 2021 |